Corient Private Wealth
RNLX

Corient Private Wealth’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Corient Private Wealth’s Portfolio RNLX Stock Details RNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-335,514
Closed -$70.2K – 2583
2024
Q3 		$70.2K Hold
335,514
– – ﹤0.01% 2367
2024
Q2 		$77.5K Hold
335,514
– – ﹤0.01% 2232
2024
Q1 		$289K Hold
335,514
– – ﹤0.01% 1915
2023
Q4 		$131K Buy
335,514
+350
+0.1% +$279 ﹤0.01% 2129
2023
Q3 		$536K Buy
335,164
+109,440
+48% +$302K ﹤0.01% 1457
2023
Q2 		$659K Buy
225,724
+10,900
+5% +$24.7K ﹤0.01% 1320
2023
Q1 		$520K Buy
214,824
+26,600
+14% +$73.8K ﹤0.01% 1369
2022
Q4 		$352K Buy
+188,224
New +$294K ﹤0.01% 1274

Other funds holding RNLX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return
IIC
Ironwood Investment Counsel Scottsdale, Arizona $694M AUM 16.84% 1-Year Est. Return

Corient Private Wealth's RNLX Position: Q4 2024 in Review

Corient Private Wealth sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 335,514 shares — an estimated $70.2K sold.

Corient Private Wealth first reported a position in RNLX in Q4 2022 and held it in 8 quarters. The position peaked at $659K in Q2 2023. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Corient Private Wealth reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Corient Private Wealth sold 335,514 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $70.2K.
  • Corient Private Wealth first reported a position in Renalytix plc American Depositary Shares in Q4 2022 and held it in 8 quarters.
  • Corient Private Wealth's Renalytix plc American Depositary Shares position peaked at $659K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Corient Private Wealth's 13F filing for Q4 2024, filed 10 Feb 2025.